RePORT ⟩ RePORTER

Project Details

Clinical Support Services for the NIAMS Intramural Research Program

Project Number1ZIDAR041180-04 NIDB ANNUAL REPORT

Contact PI/Project LeaderSIEGEL, RICHARD M

Awardee OrganizationNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES

Description

Abstract Text

This project has provided research infrastructure support for the following clinical protocols: 91-AR-0196 Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases 94-AR-0066 Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE) 94-AR-0105 Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders 99-D-0070 Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome 00-AR-0222 Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions 01-AR-0227 Natural History of Rheumatic Disease in Minority Communities 02-AR-0156 A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab in Patients with Dermatomyositis and Polymyositis 03-AR-0130 Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study 03-AR-0131 Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study 03-AR-0133 Clinically Important Changes in Rheumatoid Arthritis 03-AR-0173 Studies of the Natural History and Pathogenesis of Neonatal Onset Multisystem Inflammatory Disease (NOMID) 03-AR-0298 A Pilot Study of the IL-1 Receptor Antagonist Anakinra/Kineret in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) 04-AR-0205 Progression of Spinal Fusion in Ankylosing Spondylitis 05-AR-0014 A Pilot Open-Label Study of IL-1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis 07-E-0012 Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Polymyositis (PM) 08-AR-0008 Insulin Resistance and Atherosclerosis in a Sample of Women with Systemic Lupus Erythematosus 08-AR-0218 Rilonacept to Treat Familial Mediterranean Fever 09-AR-0066 Canakinumab to Treat Neonatal Onset Multisystem Inflammatory Disease

Public Health Relevance Statement

Data not available.

NIH Spending Category

ArthritisAutoimmune DiseaseClinical ResearchHealth ServicesPain Conditions - ChronicRare Diseases

Project Terms

AdultAdult DermatomyositisAmbulatory Care FacilitiesAnkylosing spondylitisAppointments and SchedulesArthritisAtherosclerosisClinicalClinical ProtocolsClinical ResearchCommunitiesCommunity Health CentersContractsCross-Sectional StudiesDatabasesDermatomyositisDiseaseDistrict of ColumbiaFamilial Mediterranean FeverFunctional disorderGeneticGenetic DeterminismHospitalistsInflammatoryInstitutional Review BoardsInsulin ResistanceInterleukin-1Intramural Research ProgramKineretLongitudinal StudiesMedicalMinorityNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNatural HistoryNeonatalNurse PractitionersNursing ResearchPathogenesisPatientsPhysiciansPilot ProjectsPolymyositisPreparationRandomizedRefractoryResearchResearch ActivityResearch InfrastructureResearch SupportRheumatismRheumatoid ArthritisRheumatologySalivary GlandsSamplingServicesSeveritiesSjogren's SyndromeSpinal FusionSyndromeSystemic Lupus ErythematosusTherapeuticTraining ProgramsTranslational ResearchTravelUnited States National Institutes of HealthWomananakinracostdouble-blind placebo controlled trialinfliximabopen labelprogramsreceptorrituximab

Details

Contact PI/ Project Leader

Name

SIEGEL, RICHARD M

Title

Contact

Other PIs

Not Applicable

Program Official

Name

Contact

Email not available

Organization

Name

NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES

City

Country

UNITED STATES

Department Type

Unavailable

Organization Type

Unavailable

State Code

Congressional District

Other Information

Opportunity Number

Study Section

Fiscal Year

2011

Award Notice Date

Administering Institutes or Centers

National Institute of Arthritis and Musculoskeletal and Skin Diseases

CFDA Code

DUNS Number

UEI

Project Start Date

Project End Date

Budget Start Date

Budget End Date

Project Funding Information for 2011

Total Funding

$4,112,106

Direct Costs

Indirect Costs

Year	Funding IC	FY Total Cost by IC
2011	National Institute of Arthritis and Musculoskeletal and Skin Diseases	$4,112,106

NIH Categorical SpendingClick here for more information on NIH Categorical Spending

Funding IC	FY Total Cost by IC	NIH Spending Category
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES	$4,112,106	Arthritis; Autoimmune Disease; Chronic Pain; Clinical Research; Health Services; Rare Diseases

Sub Projects

No Sub Projects information available for 1ZIDAR041180-04

Publications

Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.

No Publications available for 1ZIDAR041180-04

Patents

No Patents information available for 1ZIDAR041180-04

Outcomes

The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.

No Outcomes available for 1ZIDAR041180-04

Clinical Studies

No Clinical Studies information available for 1ZIDAR041180-04

News and More

Section Menu